Drugs / Sanggua tablets
Sanggua tablets
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT06964620 | May 2025 → Nov 2027 expected | glucose intolerance, type 2 diabetes mellitus | Tongji Hospital | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Sanggua tablets | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06964620 ↗ |
| Modality | Traditional medicine (herbal / TCM) | “Sanggua tablets, a TCM formula” NCT06964620 ↗ |